Is single-station N2 disease on PET-CT an indication for primary surgery in lung cancer patients?

Janusz Kowalewski^{1

2}, Tomasz J Szczęsny^{1

2}

Affiliations

¹ Department of Thoracic Surgery and Tumours, Faculty of Medicine, Nicolaus Copernicus University in Torun, Torun, Poland.
² Department of Thoracic Surgery and Tumours, Oncology Centre, Bydgoszcz, Poland.

Editorial

Janusz Kowalewski et al. J Thorac Dis. 2017 Dec.

. 2017 Dec;9(12):4828-4831.

doi: 10.21037/jtd.2017.10.154.

Janusz Kowalewski^{1

2}, Tomasz J Szczęsny^{1

2}

¹ Department of Thoracic Surgery and Tumours, Faculty of Medicine, Nicolaus Copernicus University in Torun, Torun, Poland.
² Department of Thoracic Surgery and Tumours, Oncology Centre, Bydgoszcz, Poland.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Is the prognosis of occult N2 disease similar to that of positive positron emission tomography-computed tomography (PET/CT) scan single-station N2 disease in patients with non-small cell lung cancer treated by surgical resection?
Honguero Martínez AF, García Jiménez MD, García Vicente A, Genovés Crespo M, Rodríguez Ortega CR, Lázaro Sahuquillo M, Soriano Castrejón ÁM, León Atance P. Honguero Martínez AF, et al. Rev Esp Med Nucl Imagen Mol. 2017 Nov-Dec;36(6):350-355. doi: 10.1016/j.remn.2017.03.011. Epub 2017 May 26. Rev Esp Med Nucl Imagen Mol. 2017. PMID: 28552624 English, Spanish.

1. Honguero Martínez AF, García Jiménez MD, García Vicente A, et al. Is the prognosis of occult N2 disease similar to that of positive positron emission tomography-computed tomography (PET/CT) scan single-station N2 disease in patients with non-small cell lung cancer treated by surgical resection? Rev Esp Med Nucl Imagen Mol 2017;36:350-5. 10.1016/j.remn.2017.03.011 - DOI - PubMed
1. Felip E, Rosell R, Maestre JA, et al. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. J Clin Oncol 2010;28:3138-45. 10.1200/JCO.2009.27.6204 - DOI - PubMed
1. Chaft JE, Rusch V, Ginsberg MS, et al. Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers. J Thorac Oncol 2013;8:1084-90. 10.1097/JTO.0b013e31829923ec - DOI - PMC - PubMed
1. Lim E, Harris G, Patel A, et al. Preoperative versus postoperative chemotherapy in patients with resectable non-small cell lung cancer: systematic review and indirect comparison meta-analysis of randomized trials. J Thorac Oncol 2009;4:1380-8. 10.1097/JTO.0b013e3181b9ecca - DOI - PubMed
1. McElnay P, Lim E. Adjuvant or neoadjuvant chemotherapy for NSCLC. J Thorac Dis 2014;6:S224-7. - PMC - PubMed